Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
But with macro issues -- ranging from the ‘Fiscal Cliff’ and the Fed to the outlook for Europe and China -- occupying investors’ attention, it isn’t clear at this stage if the deteriorating earnings picture will finally get the spotlight that it deserves.
Expectations have come down significantly enough for the fourth quarter that actual results are unlikely to be worse than what we experienced in the third quarter. Even the flat earnings growth expected this quarter is better than the negative earnings growth that was expected for the third quarter at the start of that earnings season.
In the end, third quarter earnings were a lot less negative (down only -0.1%), but that was a sharp contrast to the positive earnings growth performance quarter after quarter since 2009. Importantly, as the third quarter reporting season was getting underway, consensus estimates for the fourth quarter looked for earnings growth in excess of +7%.
The drumbeat of negative guidance on the third quarter earnings calls brought down that growth expectation from +7% to the current +0.4%. As is typically the case each quarter, most companies will likely come ahead of these lowered expectations.
Guidance from management teams on the earnings conference calls is always very important, but it will be even more critical this earnings season. In the current post-Reg FD environment, company guidance has become the primary tool through which managements anchor the market’s expectations. And earnings expectations for the coming quarters appear unusually optimistic relative to what we have seen lately.
Consensus estimates peg earnings growth to ramp up from the flat-lined performance of the second half of 2012 to a roughly +10% gain in 2013. Whether those expectations will hold or come down will depend to a large extent on how management teams describe business conditions on the fourth quarter earnings calls in the coming days.
We will know more in the coming days as the earnings picture evolves. But all indications are that estimates need to come down given the unsteady and weak state of the global economy. Revenue growth and margin expansion are the primary avenues through which earnings could grow. And both of those avenues have already played out. The market hasn’t been particularly concerned about this issue thus far, but it is difficult to envision investors shrugging lack of earnings growth for long.
RELATED ARTICLES
Earnings Season Starts This Week
Is this Rally Sustainable? (VIDEO)
Roundtable Top Picks for the Week of Jan. 7th (VIDEO)
Read the full reports :
Analyst Report on AA